Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,698Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Aarti Pharmalabs Limited

02 1Dr.Reddy's Laboratories Limited

03 1Evonik Corporation

04 1Aurisco Pharmaceutical Co.,Ltd

05 1BDR Lifesciences Private Limited

06 1Chemo Biosynthesis s.r.l.

07 1Curia New York, Inc.

08 1Hetero Labs Limited

09 1Hovione LLC

10 1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

11 1LAURUS LABS LIMITED

12 1Lonza Tampa LLC

13 1MSN Laboratories Private Limited

14 1MYLAN LABORATORIES LIMITED

15 1Optimus Drugs Private Limited

16 2ScinoPharm Taiwan Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioAsia
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

ENZALUTAMIDE

NDC Package Code : 15308-1121

Start Marketing Date : 2021-04-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (5kg/5kg)

Marketing Category : BULK INGREDIENT

Aarti Industries Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ENZALUTAMIDE

NDC Package Code : 55111-976

Start Marketing Date : 2015-03-31

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

ENZALUTAMIDE

NDC Package Code : 62128-0388

Start Marketing Date : 2015-09-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Evonik company banner

04

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

ENZALUTAMIDE

NDC Package Code : 16812-010

Start Marketing Date : 2022-10-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

BioAsia
Not Confirmed
arrow

06

BioAsia
Not Confirmed
arrow

09

BioAsia
Not Confirmed
arrow

10

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

ENZALUTAMIDE

NDC Package Code : 65015-876

Start Marketing Date : 2016-11-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

Looking for 915087-33-1 / Enzalutamide API manufacturers, exporters & distributors?

Enzalutamide manufacturers, exporters & distributors 1

43

PharmaCompass offers a list of Enzalutamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Enzalutamide manufacturer or Enzalutamide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Enzalutamide manufacturer or Enzalutamide supplier.

PharmaCompass also assists you with knowing the Enzalutamide API Price utilized in the formulation of products. Enzalutamide API Price is not always fixed or binding as the Enzalutamide Price is obtained through a variety of data sources. The Enzalutamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Enzalutamide

Synonyms

915087-33-1, Mdv3100, Mdv-3100, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-n-methylbenzamide, Mdv 3100, Enzalutamide (mdv3100)

Cas Number

915087-33-1

Unique Ingredient Identifier (UNII)

93T0T9GKNU

About Enzalutamide

Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.

Enzalutamide Manufacturers

A Enzalutamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Enzalutamide, including repackagers and relabelers. The FDA regulates Enzalutamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Enzalutamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Enzalutamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Enzalutamide Suppliers

A Enzalutamide supplier is an individual or a company that provides Enzalutamide active pharmaceutical ingredient (API) or Enzalutamide finished formulations upon request. The Enzalutamide suppliers may include Enzalutamide API manufacturers, exporters, distributors and traders.

click here to find a list of Enzalutamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Enzalutamide NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Enzalutamide as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Enzalutamide API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Enzalutamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Enzalutamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Enzalutamide NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Enzalutamide suppliers with NDC on PharmaCompass.

Enzalutamide Manufacturers | Traders | Suppliers

Enzalutamide Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.